New screening system for selective blockers of voltage-gated K(+) channels using recombinant cell lines dying upon

Masato Fujii1, Keisuke Hayashi, Susumu Ohya

  • 1Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan.

Insights

New cell lines enable simple screening for Kv1.3 and Kv1.5 channel blockers. These systems offer a high-throughput, accurate, and cost-effective method for drug discovery targeting these ion channels.

Area of Science:

  • Biophysics
  • Molecular Biology
  • Pharmacology

Background:

  • Voltage-gated potassium channels, specifically Kv1.3 and Kv1.5, are crucial in regulating cellular excitability.
  • Developing efficient screening systems for modulators of these channels is vital for therapeutic advancements.

Purpose of the Study:

  • To establish novel cell lines for the simple and accurate screening of Kv1.3 and Kv1.5 channel blockers.
  • To validate the utility of these cell lines in high-throughput screening (HTS) assays.

Main Methods:

  • Generation of cell lines co-expressing mutated Nav1.5 (IFM/Q3), Kir2.1 (Kir), and either Kv1.3 or Kv1.5.
  • Utilizing electrical stimulation (ES) to induce action potentials and subsequent cell death in the absence of functional Kv channels.
  • Assessing the protective effects of Kv channel co-expression and the inhibitory effects of known blockers (margatoxin, 4-aminopyridine, acacetin, citalopram).

Main Results:

  • Co-expression of Kv1.3 or Kv1.5 with IFM/Q3 and Kir shortened action potentials and prevented cell death induced by ES.
  • Margatoxin selectively affected the Kv1.3-expressing cell line, while 4-aminopyridine affected both.
  • Acacetin and citalopram demonstrated comparable IC50 values in both Kv1.3 and Kv1.5 expressing cell lines, indicating non-selective blockade.

Conclusions:

  • The developed cell lines (IFM/Q3+Kir+Kv1.3 and IFM/Q3+Kir+Kv1.5) serve as effective tools for screening Kv1.3 and Kv1.5 channel inhibitors.
  • These assays are suitable for high-throughput screening due to their simplicity, accuracy, and cost-effectiveness.
  • Acacetin and citalopram are identified as non-selective blockers of both Kv1.3 and Kv1.5 channels.